• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病患者中肌肉减少症的患病率及其与疾病活动的相关性和对预后的影响。

The Prevalence of Sarcopenia in Crohn's Disease Patients and Its Correlation With Disease Activity and Effect on Prognosis.

作者信息

Kadavanoor Srijith, Krishnadas P Susruth, Peumpalath Naufal, K Sunil Kumar, Balagopal Sithara K

机构信息

Department of Gastroenterology, Government Medical College Hospital, Thrissur, IND.

Department of Gastroenterology, Government Medical College Hospital, Kozhikode, IND.

出版信息

Cureus. 2025 May 6;17(5):e83579. doi: 10.7759/cureus.83579. eCollection 2025 May.

DOI:10.7759/cureus.83579
PMID:40476129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12140091/
Abstract

Introduction Crohn's disease (CD) is a chronic inflammatory disorder that can involve any part from mouth to anus but predominantly involves the distal small intestine and proximal colon. Sarcopenia is recognized as muscle failure consequent to loss of skeletal muscle strength, function, and mass. Sarcopenia was found to be prevalent in CD patients. Objectives The primary objective of our study was to assess the prevalence of sarcopenia in CD patients, its correlation with disease activity, and the effect of sarcopenia on the prognosis of CD. The secondary objectives were to find out whether there is any correlation of sarcopenia with C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin, and hemoglobin levels. Materials and methods This was a prospective cohort study done on 70 newly diagnosed CD patients in the Department of Gastroenterology, Government Medical College, Kozhikode, Kerala, India. Sarcopenia was assessed with the L3 skeletal muscle index (L3SMI) using a cross-sectional image at the L3 level from a cross-sectional image using Image J software. The cut-off of L3SMI was < 36.5 cm²/m² and 30.2 cm²/m² for male patients and female patients, respectively. The prevalence of sarcopenia was assessed. Its effect on clinical and endoscopic disease severity as well as blood parameters was assessed, and the outcome was measured by clinical remission, response to therapy, and number of disease flares. Results The study included 70 newly diagnosed CD patients above 18 years. Out of 70 patients, 26 were female patients and 44 were male patients. The mean age of the study population was 29.86. Mean L3SMI of the population was 37.35 ± 6.63 cm/m. Prevalence of sarcopenia was 38.6% (n=27). The sarcopenia group had a younger age of disease onset (24.52 ± 8.22). Body mass index (BMI) was lower in the sarcopenia group (15.12 ± 1.33 kg/m). Patients with sarcopenia had higher clinical disease severity according to the Crohn's disease activity index (CDAI) score and higher endoscopic severity according to the simple endoscopic score (SES-CD score). Hemoglobin and albumin were lower, and CRP and ESR were higher in the sarcopenia group. Remission at six-month follow-up was 48.1% in the sarcopenia group and was lower when compared to the group without sarcopenia. The number of disease flares was higher in the sarcopenia group (1.07 ± 1.035).  Conclusion Sarcopenia is prevalent in CD patients. Patients with sarcopenia had higher clinical and endoscopic disease severity. There is decreased remission and an increased number of flares in patients with sarcopenia. Sarcopenia correlated with hemoglobin, albumin, CRP, and ESR.

摘要

引言

克罗恩病(CD)是一种慢性炎症性疾病,可累及从口腔到肛门的任何部位,但主要累及远端小肠和近端结肠。肌肉减少症被认为是骨骼肌力量、功能和质量丧失导致的肌肉功能衰竭。研究发现肌肉减少症在CD患者中很普遍。

目的

我们研究的主要目的是评估CD患者中肌肉减少症的患病率、其与疾病活动度的相关性以及肌肉减少症对CD预后的影响。次要目的是确定肌肉减少症与C反应蛋白(CRP)、红细胞沉降率(ESR)、白蛋白和血红蛋白水平是否存在任何相关性。

材料和方法

这是一项前瞻性队列研究,对印度喀拉拉邦科泽科德政府医学院胃肠病学系的70例新诊断的CD患者进行。使用Image J软件从L3水平的横断面图像评估L3骨骼肌指数(L3SMI)来评估肌肉减少症。男性患者和女性患者的L3SMI临界值分别为<36.5 cm²/m²和30.2 cm²/m²。评估肌肉减少症的患病率。评估其对临床和内镜疾病严重程度以及血液参数的影响,并通过临床缓解、对治疗的反应和疾病发作次数来衡量结果。

结果

该研究纳入了70例18岁以上新诊断的CD患者。70例患者中,26例为女性患者,44例为男性患者。研究人群的平均年龄为29.86岁。人群的平均L3SMI为37.35±6.63 cm/m。肌肉减少症的患病率为38.6%(n = 27)。肌肉减少症组的疾病发病年龄较轻(24.52±8.22)。肌肉减少症组的体重指数(BMI)较低(15.12±1.33 kg/m)。根据克罗恩病活动指数(CDAI)评分,肌肉减少症患者的临床疾病严重程度较高,根据简单内镜评分(SES-CD评分),内镜严重程度也较高。肌肉减少症组的血红蛋白和白蛋白较低,CRP和ESR较高。肌肉减少症组在6个月随访时的缓解率为48.1%,与无肌肉减少症组相比更低。肌肉减少症组的疾病发作次数更高(1.07±1.035)。

结论

肌肉减少症在CD患者中很普遍。肌肉减少症患者的临床和内镜疾病严重程度较高。肌肉减少症患者的缓解率降低,发作次数增加。肌肉减少症与血红蛋白、白蛋白、CRP和ESR相关。

相似文献

1
The Prevalence of Sarcopenia in Crohn's Disease Patients and Its Correlation With Disease Activity and Effect on Prognosis.克罗恩病患者中肌肉减少症的患病率及其与疾病活动的相关性和对预后的影响。
Cureus. 2025 May 6;17(5):e83579. doi: 10.7759/cureus.83579. eCollection 2025 May.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.前瞻性研究阿达木单抗联合部分肠内营养在克罗恩病诱导期的应用。
Inflamm Res. 2024 Feb;73(2):199-209. doi: 10.1007/s00011-023-01828-7. Epub 2024 Jan 2.
4
Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.克罗恩病的简易肠道造影活动评分:与内镜、生化及临床检查结果的比较
Pol Arch Med Wewn. 2013;123(7-8):378-85. doi: 10.20452/pamw.1825. Epub 2013 Jun 14.
5
The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease.克罗恩病患者中肌肉减少症的患病率及其对预后的影响。
Intest Res. 2020 Jan;18(1):79-84. doi: 10.5217/ir.2019.00107. Epub 2020 Jan 30.
6
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.非侵入性评估在监测炎症性肠病活动中的疗效:中国的一项前瞻性研究。
World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.
7
[Value of different endoscopic scoring methods in assessing disease activity in pediatric Crohn's disease].[不同内镜评分方法在评估儿童克罗恩病疾病活动度中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):584-591. doi: 10.7499/j.issn.1008-8830.2311103.
8
Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.中国克罗恩病患者中与肌肉减少症相关的身体成分成像参数评估:与疾病严重程度和生物制剂疗效的相关性
Am J Transl Res. 2024 Oct 15;16(10):5427-5440. doi: 10.62347/ZPZR8134. eCollection 2024.
9
[Correlation between contrast-enhanced ultrasound parameters and Crohn's disease activity].[超声造影参数与克罗恩病活动度的相关性]
Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):427-432. doi: 10.3760/cma.j.cn112138-20220411-00263.
10
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.用于评估克罗恩病疾病活动度的内镜评分指标。
Cochrane Database Syst Rev. 2016 Aug 8;2016(8):CD010642. doi: 10.1002/14651858.CD010642.pub2.

本文引用的文献

1
Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis.肌肉减少症对手术患者结局的影响:系统评价和荟萃分析。
Int J Surg. 2023 Dec 1;109(12):4238-4262. doi: 10.1097/JS9.0000000000000688.
2
Nutritional screening and assessment in inflammatory bowel disease.炎症性肠病的营养筛查与评估
Indian J Gastroenterol. 2022 Feb;41(1):5-22. doi: 10.1007/s12664-021-01223-2. Epub 2022 Jan 15.
3
Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease.炎症性肠病患者的营养不良患病率、相关危险因素,以及营养支持的应用。
Inflamm Bowel Dis. 2022 Jun 2;28(Suppl 2):S59-S66. doi: 10.1093/ibd/izab345.
4
Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease.肌肉减少症与高内脏脂肪的联合预测克罗恩病患者的不良结局。
Eur J Clin Nutr. 2021 Oct;75(10):1491-1498. doi: 10.1038/s41430-021-00857-x. Epub 2021 Feb 2.
5
The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease.克罗恩病患者中肌肉减少症的患病率及其对预后的影响。
Intest Res. 2020 Jan;18(1):79-84. doi: 10.5217/ir.2019.00107. Epub 2020 Jan 30.
6
Nutritional Rehabilitation in Patients with Malnutrition Due to Crohn's Disease.克罗恩病所致营养不良患者的营养康复。
Nutrients. 2019 Dec 4;11(12):2947. doi: 10.3390/nu11122947.
7
ESPEN guideline: Clinical nutrition in inflammatory bowel disease.ESPEN 指南:炎症性肠病的临床营养。
Clin Nutr. 2017 Apr;36(2):321-347. doi: 10.1016/j.clnu.2016.12.027. Epub 2016 Dec 31.
8
A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol.将握力测量纳入医院常规实践的可行性研究(GRImP):研究方案
Pilot Feasibility Stud. 2016 Jun 6;2:27. doi: 10.1186/s40814-016-0067-x. eCollection 2016.
9
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes.SARC - F:一种用于预测有肌肉减少症风险且功能预后较差人群的症状评分。
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36. doi: 10.1002/jcsm.12048. Epub 2015 Jul 7.
10
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.握力的预后价值:来自前瞻性城乡流行病学(PURE)研究的结果。
Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13.